Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP2 | P50579 | 1/20 | 0.52 |
| ▸ | KIF11 | P52732 | 1/20 | 0.51 |
| ▸ | IDO1 | P14902 | 1/20 | 0.48 |
| ▸ | PPARG | P37231 | 2/20 | 0.46 |
| ▸ | PPARA | Q07869 | 2/20 | 0.46 |
| ▸ | ACE | P12821 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | LTA4H | P09960 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4141148 | 1.00 | METAP2 (0.52) | METAP2KIF11IDO1PPARGPPARA | |
| SCHEMBL1839764 | 1.00 | METAP2 (0.52) | METAP2KIF11IDO1PPARGPPARA | |
| Hydrochloric Acid SCHEMBL3119114 | 0.98 | METAP2 (0.51) | METAP2KIF11IDO1PPARGPPARA | |
| Hydrochloric Acid SCHEMBL4141147 | 0.98 | METAP2 (0.51) | METAP2KIF11IDO1PPARGPPARA | |
| Hydrochloric Acid SCHEMBL2971264 | 0.98 | METAP2 (0.51) | METAP2KIF11IDO1PPARGPPARA | |
| Hydrochloric Acid SCHEMBL2123378 | 0.97 | METAP2 (0.50) | METAP2KIF11IDO1PPARGPPARA | |
| Cyanide SCHEMBL28390031 | 0.96 | METAP2 (0.49) | METAP2KIF11IDO1PPARGPPARA | |
| SCHEMBL2238552 | 0.86 | METAP2 (0.60) | METAP2IDO1PPARGPPARAACE | |
| SCHEMBL31512919 | 0.86 | KIF11 (0.50) | METAP2KIF11IDO1L3MBTL1LTA4H | |
| SCHEMBL7303633 | 0.86 | KIF11 (0.50) | METAP2KIF11L3MBTL1LTA4HMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2556051-A1 | PROCESS FOR PRODUCING SULFUR-CONTAINING AMINO ACIDS | Sumitomo Chemical Company, Limited (JP) | 2013-02-13 | — | — | EP | disclosed |
| US-20130023696-A1 | PROCESS FOR PRODUCING SULFUR-CONTAINING AMINO ACIDS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-01-24 | — | — | US | disclosed |
| CN-102834376-A | Process for producing sulfur-containing amino acids | SUMITOMO CHEMICAL CORP | 2012-12-19 | — | — | CN | disclosed |
| WO-2011126129-A1 | PROCESS FOR PRODUCING SULFUR-CONTAINING AMINO ACIDS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-10-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130023696-A1 | PROCESS FOR PRODUCING SULFUR-CONTAINING AMINO ACIDS | CBS, CTH, BCAT2 | METAP2 23/4885KIF11 4625/4885IDO1 182/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.